What EnvoyAI does

EnvoyAI is a Cambridge, Massachusetts-based private company founded in 2016 that delivers AI-powered medical imaging software for clinical workflows in radiology, cardiology, and neurology. Its operating identity in the market is TeraRecon, a wholly-owned subsidiary of ConcertAI, which provides advanced visualization and AI decision support to hospitals, health systems, and academic medical centers. Named flagship customers include Emory University (cardiothoracic radiology) and Duke University (lung screening and chest radiograph analysis).

The technology stack centers on a SaaS-based advanced medical imaging platform composed of three flagship products: TeraRecon AV (next-generation SaaS visualization platform with AI-driven automations, registered as 'Intuition' in global markets), TeraRecon DETECT (AI Biomarker solution enabling enterprise-wide adoption of reimbursable AI findings), and TeraRecon Neuro (neurology imaging analysis). Supporting capabilities include proprietary Bone Suppression technology for chest radiographs and an Enterprise Imaging Decision Support layer that allows physicians to accept, reject, or adjust AI findings from the surgical suite through point of care. The platform is integrated into hospital IT environments through formalized AI Partners and PACS Partners channel ecosystems.

The business model is subscription-based enterprise SaaS sold via direct field sales to healthcare providers, with 'Request a Demo' and 'Free Trial' CTAs on the website indicating a consultative enterprise sales motion. Pricing is not publicly disclosed and is negotiated bespoke. The company targets enterprise healthcare buyers (academic medical centers, hospitals, health systems) and pursues a vertical segmentation approach across radiology, cardiology, and neurology departments, with reimbursement-eligible AI Biomarkers as a key monetization lever. Founder and CEO is Misha Herscu; the firm is listed with 1–10 employees, though TeraRecon's operating scale is embedded within parent ConcertAI.

Name

EnvoyAI

Legal name

TeraRecon

Website

https://envoyai.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

EnvoyAI (operating as TeraRecon) provides AI-powered SaaS medical imaging software for radiology, cardiology, and neurology workflows at hospitals and academic medical centers, with flagship products including TeraRecon AV, DETECT AI Biomarkers, and Neuro, distributed through direct enterprise sales and PACS/AI partner channels.

Ownership category

akta.pro rank

Product category

AI Medical Imaging Software

NAICS

Software Publishers (513210)

SIC

Services-Computer Integrated Systems Design (7373)

akta.pro primary industry

SaMD – Imaging & Signal Analysis (AI/ML) (HLACANAG)

akta.pro secondary industries

Radiology AI, CAD & Advanced Visualization Software (HLAHABAJ), Vendor Neutral Archive (VNA) & Enterprise Imaging Repositories (HLACALAC), Imaging & Diagnostic Interoperability (DICOM exchange, image sharing, VNA connectivity) (HLACABAM)

Keywords

• AI medical imaging
• Advanced visualization
• Radiology AI software
• Medical imaging SaaS
• AI biomarker imaging

Headquarters

HQ city

Cambridge

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Subscription-based SaaS Platform: Consolidates multiple 3D and AI solutions into one powerful, subscription-based platform. The company positions itself as simplifying and scaling imaging workflows through a consolidated platform approach, reducing costs by replacing multiple point solutions.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

EnvoyAI sells a SaaS-based AI-driven advanced medical imaging platform that consolidates multiple 3D visualization and AI biomarker solutions into a single subscription product for healthcare providers. The platform serves radiology, cardiology, and neurology imaging workflows with proprietary capabilities including TeraRecon AV (advanced visualization), TeraRecon DETECT (AI biomarker adoption), TeraRecon Neuro (neurology imaging), and Bone Suppression technology, enabling diagnostic precision, workflow efficiency, and reimbursable AI biomarker adoption across the imaging enterprise.

Differentiator

Problem solved

Functional benefit

Brands

• TeraRecon AV: SaaS-based advanced medical imaging platform with AI-driven automations for diagnostic precision, efficiency, and care.
• TeraRecon DETECT
• TeraRecon Neuro
• TeraRecon Intuition

Products and services

• TeraRecon AV Next-generation SaaS-based advanced medical imaging platform with AI-driven automations for diagnostic precision, efficiency, and care enhancement across radiology, cardiology, and neurology. Registered as Intuition in global markets outside the TeraRecon AV branding.
• TeraRecon DETECT AI-powered workflow solution helping healthcare providers drive adoption of reimbursable AI Biomarkers across their entire imaging enterprise. Components awaiting regulatory clearance in some markets.
• TeraRecon Neuro AI-powered neurology imaging analysis and visualization solution for neuro imaging workflows across healthcare enterprises.
• TeraRecon Intuition Advanced visualization solution registered as Intuition in global markets outside the TeraRecon AV branding, providing the same underlying advanced imaging capabilities under regional naming.
• Premier Success Premium customer support and success service for TeraRecon imaging customers, providing dedicated technical assistance, training, and ongoing optimization for enterprise deployments.

Quantifiable outcome

• AI-driven efficiency gains at important steps of the patient care path; increased throughput while saving physician and technologist time; improvements in time-to-treatment and patient outcomes

Named customers2 records

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• ConcertAIcoreStrategic or Co-development PartnerConcertAI is the parent company of TeraRecon. TeraRecon represents ConcertAI's imaging solutions division. The company operates under the ConcertAI umbrella with shared branding and website domains (concertai.com). TeraRecon AV is described as the next generation of ConcertAI's imaging solutions.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Viz.ai: Viz.ai delivers AI-driven care coordination and image analysis, most prominently for stroke and neurovascular workflows. It overlaps with TeraRecon Neuro on AI neurology imaging and is a direct enterprise radiology-AI competitor.
• Aidoc: Aidoc provides an AI-powered clinical decision support and workflow platform for radiology, with FDA-cleared algorithms deployed across hospital systems. It directly competes with TeraRecon DETECT/Neuro on AI-augmented radiology workflows and enterprise imaging decision support.
• Caption Health (GE HealthCare): Caption Health developed AI-guided ultrasound acquisition and interpretation, particularly for cardiology. It competes with TeraRecon on AI-augmented cardiac imaging workflows and was acquired by GE HealthCare in Feb 2023.
• Arterys: Arterys offers a cloud-native AI imaging platform with deep-learning quantification across radiology and cardiology. It mirrors TeraRecon's SaaS-based advanced visualization and AI-augmented imaging approach.
• Blackford Analysis: Blackford provides an AI platform and marketplace that curates and distributes third-party radiology AI algorithms to imaging providers. It directly parallels TeraRecon's AI Partners channel and DETECT biomarker marketplace approach (now owned by Bayer).
• Zebra Medical Vision: Zebra Medical Vision develops AI algorithms for radiology imaging interpretation across multiple modalities and clinical conditions. Now part of Nanox, it competes with TeraRecon on AI imaging analytics and enterprise deployment.

Broad incumbents

• Siemens Healthineers (AI-Rad Companion): Siemens Healthineers provides AI-Rad Companion and a wide range of imaging equipment and enterprise imaging software. It competes with TeraRecon at the modality/enterprise level, bundling AI into its broader imaging ecosystem.
• GE HealthCare (Edison): GE HealthCare operates the Edison AI platform across imaging devices and software. Following the Caption Health acquisition, it is increasingly a direct AI imaging competitor and a broad incumbent in TeraRecon's enterprise accounts.
• Philips (IntelliSpace AI): Philips offers IntelliSpace AI and a broad portfolio of imaging hardware, PACS, and clinical informatics. As a major incumbent, it competes indirectly through bundled enterprise imaging contracts and AI capabilities across its installed base.
• Nanox (formerly Nano-X Imaging): Nanox is building a multi-vendor imaging and AI platform, including through its Zebra Medical Vision acquisition. It overlaps with TeraRecon on AI imaging software distribution and enterprise imaging services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/envoyai

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about EnvoyAI